MarketCap
Facebook
X
Telegram
Applied Therapeutics Langfristiger Schuldenstrom | APLT
Langfristiger Schuldenstrom Jährlich Applied Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 406 K | 429 K | 477 K | 442 K | 406 K | 356 K | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 477 K | 356 K | 419 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akari Therapeutics, Plc
AKTX
|
4.6 M | $ 7.0 | -8.62 % | $ 471 B |  Britain |
 |
Mersana Therapeutics
MRSN
|
3.86 M | - | - | $ 3.56 B |  USA |
 |
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
2.66 M | - | - | $ 384 M | Britain |
 |
Genmab A/S
GMAB
|
26 M | $ 54.08 | -3.08 % | $ 3.5 B |  Danmark |
 |
Allakos
ALLK
|
4.16 M | - | - | $ 28.6 M | USA |
 |
Timber Pharmaceuticals
TMBR
|
331 K | - | - | $ 717 K | USA |
 |
Immuron Limited
IMRN
|
40.6 K | $ 0.9 | 2.27 % | $ 208 M |  Australia |
 |
G1 Therapeutics
GTHX
|
1.28 M | - | - | $ 370 M | USA |
 |
Amryt Pharma plc
AMYT
|
1.54 M | - | - | $ 621 M | Britain |
 |
BioVie
BIVI
|
91 K | $ 1.25 | -3.85 % | $ 9.06 M | USA |
 |
Kinnate Biopharma
KNTE
|
892 K | - | - | $ 123 M | USA |
 |
Mustang Bio
MBIO
|
456 K | $ 0.44 | 12.95 % | $ 2.16 M | USA |
|
Cerevel Therapeutics Holdings
CERE
|
3.4 M | - | - | $ 7.29 B | USA |
 |
NexImmune
NEXI
|
68.8 K | - | 70.13 % | $ 4.12 M | USA |
 |
Codexis
CDXS
|
2.94 M | $ 1.0 | -9.91 % | $ 87.1 M | USA |
 |
Theravance Biopharma
TBPH
|
10.9 M | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Compugen Ltd.
CGEN
|
521 K | $ 2.06 | -3.72 % | $ 192 M |  Israel |
 |
IMV
IMV
|
320 K | - | - | $ 13.1 M |  Canada |
 |
Sanofi
SNY
|
272 M | $ 48.23 | 0.22 % | $ 58.9 B |  France |
 |
Karuna Therapeutics
KRTX
|
2.84 M | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
719 K | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
1.23 M | - | - | $ 229 M | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
353 K | $ 0.38 | -5.06 % | $ 4.68 B | Israel |
|
89bio
ETNB
|
727 K | - | - | $ 1.55 B | USA |
 |
Fusion Pharmaceuticals
FUSN
|
4.16 M | - | - | $ 1.41 B | Canada |
 |
Gritstone Oncology
GRTS
|
6.9 M | - | 0.42 % | $ 213 M | USA |
 |
Harpoon Therapeutics
HARP
|
2.42 M | - | - | $ 763 M | USA |
 |
HOOKIPA Pharma
HOOK
|
552 K | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
3.81 K | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
338 K | - | - | $ 109 M | USA |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
3.36 M | - | -1.96 % | $ 4.68 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | USA |
 |
Seagen
SGEN
|
14.5 M | - | - | $ 42.2 B | USA |
|
Protara Therapeutics
TARA
|
1.24 M | $ 2.44 | -2.59 % | $ 105 M | USA |
 |
Baudax Bio
BXRX
|
5.6 M | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
2.81 M | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
1.61 M | - | 7.23 % | $ 2.72 M | USA |
 |
Oncternal Therapeutics
ONCT
|
173 K | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
67 K | - | - | $ 591 K |  Irlanda |
 |
Spectrum Pharmaceuticals
SPPI
|
761 K | - | - | $ 189 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Alpine Immune Sciences
ALPN
|
912 K | - | - | $ 2.17 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
1.16 M | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
4.1 M | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
445 K | - | -8.77 % | $ 12.4 M | Israel |
 |
Histogen
HSTO
|
238 K | - | 31.6 % | $ 2.12 M | USA |